Dr. Tetsuyuki Maruyama

linkedin-icon-32x32.png

Dr. Tetsuyuki Maruyama is an independent pharmaceutical and biotech consultant. He previously held faculty positions at the University of Minnesota and Cardiff University where he focused on the neurobiology of learning and memory. Tetsu then held leadership positions in CNS drug discovery for Merck Sharp and Dohme in the UK and for GlaxoSmithKline in Singapore before becoming SVP of Drug Discovery at Takeda. In 2016 he joined the Dementia Discovery Fund as Chief Scientist, a position he held until the end of 2019. Tetsu is on the Boards of a number of privately held biotech companies and non-profits.